You are here
Shaping the future of life sciences in Europe
What does the future hold for Europe's life sciences sector? On Tuesday, 19 September, AmCham EU explored this question, hearing policy and industry perspectives during a panel discussion. The attention was on recent legislative changes within the EU and the challenges they may pose to transatlantic cooperation on health policy. By innovating together, the EU and US can set a promising future for the life sciences sector, enhancing health policy and advancing global well-being.
![](http://amchameu.eu/sites/default/files/styles/news_thumbnail/public/news/microsoftteams-image_437_1.png?itok=LGUNQv26&c=0349872948ad310e4accb2cf275ac4d1)
The panel was moderated by Andrea Chiarello (Pfizer), Chair, Healthcare Committee, AmCham EU where members heard from Meredith Broadbent, Senior Adviser (Non-resident), Centre for Strategic and International Studies; Gloria Ghéquière, Adviser, Cabinet of Deputy Prime Minister Franck Vandenbroucke, Belgian Federal Government; and Elizabeth Kuiper, Associate Director, European Policy Centre.